Intuitive Surgical is trading 4.6% down at $379.41, as investors weigh earlier concerns about slowing U.S. da Vinci procedure growth.
- No fresh company-specific announcement or analyst action was identified for August 20, 2026.
- Investors are also weighing competitive pressure and a cautious outlook despite the second-quarter earnings beat.
- Major indexes are declining, while healthcare is outperforming; sector strength does not clearly explain the drop.